Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning

Azoulay E.

Source: Eur Respir J 2009; 33: 6-8
Journal Issue: January

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Azoulay E.. Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning. Eur Respir J 2009; 33: 6-8

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical reasoning in patients with pulmonary infiltrates and haematological malignancies
Source: Annual Congress 2010 - The lung in haematological disorders
Year: 2010


Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010


Rituximab-induced lung disease: a systematic literature review
Source: Eur Respir J 2010; 35: 681-687
Year: 2010



Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010


Lymphoid interstitial pneumonia: clinical features, associations and prognosis
Source: Eur Respir J 2006; 28: 364-369
Year: 2006



Pulmonary complications in patients with hematologic diseases
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Severe sarcoidosis: clinical features and management
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Pulmonary tumor thrombotic microangiopathy: A clinical analysis of 30 autopsy cases
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013

B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006

Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Manifestations of malignancies during the course of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Pulmonary and extra-pulmonary characteristics in two distinct type of hematologic malignancies
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017